WallStSmart
ABVC

ABVC Biopharma Inc

NASDAQ: ABVC · HEALTHCARE · BIOTECHNOLOGY

$1.03
-3.74% today

Updated 2026-04-29

Market cap
$26.41M
P/E ratio
P/S ratio
27.42x
EPS (TTM)
$-0.39
Dividend yield
52W range
$1 – $5
Volume
0.1M

ABVC Biopharma Inc (ABVC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112014201520162017201720182019202020212022202320242025
Operating cash flow$-18427.00$24454.00$-2.69M$-2.34M$-1.56M$-1.05M$-1.59M$1168.00$3360.00$-3.47M$-1.60M$-1.68M$-630195.00$-3.13M$-4.56M$-7.60M$-7.40M$-4.19M$-1.81M$-2.99M
Capital expenditures$0.00$0.00$97564.00$215942.00$59441.00$11368.00$41745.00$19546.00$0.00$0.00$0.00$0.00$17503.00$17503.00$17503.00$17503.00$119692.00$21201.00$0.00$5791.00
Depreciation
Stock-based comp$730243.00$196121.00$30000.00$1.30M$155400.00$28800.00$22314.00$4.15M$5.31M$7.04M$185933.00$2.77M$4.14M
Free cash flow$-18427.00$24454.00$-2.79M$-2.55M$-1.62M$-1.06M$-1.63M$-18378.00$3360.00$-3.47M$-1.60M$-1.68M$-647698.00$-3.15M$-4.58M$-7.62M$-7.52M$-4.21M$-1.81M$-2.99M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash